CalciMedica Common Stock Forecast - Naive Prediction
| CALC Stock | 1.25 3.87 75.59% |
CalciMedica Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast CalciMedica Common stock prices and determine the direction of CalciMedica Common Stock's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of CalciMedica Common's historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of CalciMedica Common's share price is below 30 at the present time suggesting that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling CalciMedica Common Stock, making its price go up or down. Momentum 29
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.38) | EPS Estimate Current Year (1.63) | EPS Estimate Next Year (1.63) | Wall Street Target Price 16.25 | EPS Estimate Current Quarter (0.41) |
Using CalciMedica Common hype-based prediction, you can estimate the value of CalciMedica Common Stock from the perspective of CalciMedica Common response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of CalciMedica Common Stock on the next trading day is expected to be 1.40 with a mean absolute deviation of 0.39 and the sum of the absolute errors of 24.45. CalciMedica Common after-hype prediction price | USD 1.25 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CalciMedica | Build AI portfolio with CalciMedica Stock |
CalciMedica Common Additional Predictive Modules
Most predictive techniques to examine CalciMedica price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CalciMedica using various technical indicators. When you analyze CalciMedica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
CalciMedica Common Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the CalciMedica Common's financial statements to predict how it will affect future prices.
Cash | First Reported 2019-12-31 | Previous Quarter 5.9 M | Current Value 5.5 M | Quarterly Volatility 18.7 M |
CalciMedica Common Naive Prediction Price Forecast For the 30th of January
Given 90 days horizon, the Naive Prediction forecasted value of CalciMedica Common Stock on the next trading day is expected to be 1.40 with a mean absolute deviation of 0.39, mean absolute percentage error of 0.27, and the sum of the absolute errors of 24.45.Please note that although there have been many attempts to predict CalciMedica Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that CalciMedica Common's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
CalciMedica Common Stock Forecast Pattern
| Backtest CalciMedica Common | CalciMedica Common Price Prediction | Buy or Sell Advice |
CalciMedica Common Forecasted Value
In the context of forecasting CalciMedica Common's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. CalciMedica Common's downside and upside margins for the forecasting period are 0.01 and 13.56, respectively. We have considered CalciMedica Common's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of CalciMedica Common stock data series using in forecasting. Note that when a statistical model is used to represent CalciMedica Common stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.6391 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3944 |
| MAPE | Mean absolute percentage error | 0.1067 |
| SAE | Sum of the absolute errors | 24.4517 |
Predictive Modules for CalciMedica Common
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CalciMedica Common Stock. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CalciMedica Common After-Hype Price Density Analysis
As far as predicting the price of CalciMedica Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CalciMedica Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CalciMedica Common, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CalciMedica Common Estimiated After-Hype Price Volatility
In the context of predicting CalciMedica Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CalciMedica Common's historical news coverage. CalciMedica Common's after-hype downside and upside margins for the prediction period are 0.06 and 13.31, respectively. We have considered CalciMedica Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CalciMedica Common is out of control at this time. Analysis and calculation of next after-hype price of CalciMedica Common Stock is based on 3 months time horizon.
CalciMedica Common Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as CalciMedica Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CalciMedica Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CalciMedica Common, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 12.16 | 0.01 | 0.00 | 6 Events / Month | 7 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.25 | 1.25 | 0.00 |
|
CalciMedica Common Hype Timeline
CalciMedica Common Stock is currently traded for 1.25. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. CalciMedica is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -0.12%. %. The volatility of related hype on CalciMedica Common is about 64000.0%, with the expected price after the next announcement by competition of 1.25. About 24.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.62. CalciMedica Common Stock had not issued any dividends in recent years. The entity had 1:14 split on the 20th of March 2023. Given the investment horizon of 90 days the next expected press release will be in about 6 days. Check out Historical Fundamental Analysis of CalciMedica Common to cross-verify your projections.CalciMedica Common Related Hype Analysis
Having access to credible news sources related to CalciMedica Common's direct competition is more important than ever and may enhance your ability to predict CalciMedica Common's future price movements. Getting to know how CalciMedica Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CalciMedica Common may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TVRD | Tvardi Therapeutics | 0.1 | 8 per month | 0.00 | (0.11) | 5.59 | (5.80) | 17.33 | |
| LTRN | Lantern Pharma | (0.13) | 8 per month | 0.00 | (0.04) | 10.27 | (5.57) | 23.91 | |
| LVTX | LAVA Therapeutics NV | 0.15 | 28 per month | 1.19 | 0.06 | 4.70 | (2.63) | 14.75 | |
| ATNM | Actinium Pharmaceuticals | (0.16) | 22 per month | 0.00 | (0.03) | 6.29 | (5.33) | 25.17 | |
| ELUT | Elutia Inc | 0.04 | 6 per month | 4.97 | 0.05 | 9.52 | (7.27) | 33.48 | |
| RVPH | Reviva Pharmaceuticals Holdings | 0.10 | 7 per month | 0.00 | (0.07) | 10.71 | (12.50) | 65.06 | |
| XLO | Xilio Development | (0.01) | 10 per month | 0.00 | (0.12) | 4.69 | (5.56) | 15.41 | |
| PDSB | PDS Biotechnology Corp | 0.10 | 8 per month | 4.61 | 0.01 | 8.60 | (8.41) | 27.78 | |
| MAIA | MAIA Biotechnology | 0.01 | 11 per month | 5.73 | 0.16 | 12.60 | (8.28) | 35.91 | |
| RNXT | RenovoRx | (0.01) | 10 per month | 0.00 | (0.05) | 9.90 | (7.08) | 32.58 |
Other Forecasting Options for CalciMedica Common
For every potential investor in CalciMedica, whether a beginner or expert, CalciMedica Common's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CalciMedica Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CalciMedica. Basic forecasting techniques help filter out the noise by identifying CalciMedica Common's price trends.CalciMedica Common Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CalciMedica Common stock to make a market-neutral strategy. Peer analysis of CalciMedica Common could also be used in its relative valuation, which is a method of valuing CalciMedica Common by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
CalciMedica Common Market Strength Events
Market strength indicators help investors to evaluate how CalciMedica Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CalciMedica Common shares will generate the highest return on investment. By undertsting and applying CalciMedica Common stock market strength indicators, traders can identify CalciMedica Common Stock entry and exit signals to maximize returns.
CalciMedica Common Risk Indicators
The analysis of CalciMedica Common's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in CalciMedica Common's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting calcimedica stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.44 | |||
| Standard Deviation | 11.61 | |||
| Variance | 134.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for CalciMedica Common
The number of cover stories for CalciMedica Common depends on current market conditions and CalciMedica Common's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CalciMedica Common is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CalciMedica Common's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
CalciMedica Common Short Properties
CalciMedica Common's future price predictability will typically decrease when CalciMedica Common's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CalciMedica Common Stock often depends not only on the future outlook of the potential CalciMedica Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CalciMedica Common's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.2 M | |
| Cash And Short Term Investments | 18.7 M |
Check out Historical Fundamental Analysis of CalciMedica Common to cross-verify your projections. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Biotechnology sector continue expanding? Could CalciMedica diversify its offerings? Factors like these will boost the valuation of CalciMedica Common. Projected growth potential of CalciMedica fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CalciMedica Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of CalciMedica Common Stock is measured differently than its book value, which is the value of CalciMedica that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica Common's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because CalciMedica Common's market value can be influenced by many factors that don't directly affect CalciMedica Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CalciMedica Common's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CalciMedica Common should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CalciMedica Common's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.